To understand if the intestinal chronic activation of Lxr was able to promote hepatic cancer, we took advantage of iVP16LXRα mice, in which the constitutively activated form of human LXRα (VP16LXRα) was under the control of the enterocyte-specific Villin promoter [19]. This evidence concerns the gene NR1H3 and liver cancer.